Literature DB >> 2998407

Antiarthritic drugs containing thiol groups scavenge hypochlorite and inhibit its formation by myeloperoxidase from human leukocytes. A therapeutic mechanism of these drugs in rheumatoid arthritis?

R A Cuperus, A O Muijsers, R Wever.   

Abstract

We investigated the effect of antiarthritic drugs containing thiol groups, such as D-penicillamine, tiopronin (N-[2-mercaptopropionyl]glycine), sodium aurothiomalate, and aurothioglucose, on the chlorinating activity of myeloperoxidase purified from human leukocytes. Hypochlorite, the reactive product of the reaction catalyzed by myeloperoxidase, was effectively scavenged by these antiarthritic drugs, and in addition, D-penicillamine and tiopronin inhibited myeloperoxidase itself. The above-mentioned effects of these drugs were observed at concentrations that occur in the serum of rheumatoid arthritis patients treated with these agents. We suggest that the therapeutic effect of these antiarthritic drugs may be due to the protection of tissues against the reactive HOCI released by activated granulocytes at inflamed sites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998407     DOI: 10.1002/art.1780281106

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

1.  Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity.

Authors:  A E Koch; J C Burrows; P J Polverini; M Cho; S J Leibovich
Journal:  Agents Actions       Date:  1991-11

2.  The effect of sodium aurothiomalate on stimulated and non-stimulated migration by human neutrophils: the role of cyclic GMP.

Authors:  J G Elferink; M R Daha; B M De Koster
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

3.  Failure of oral thiomalate to act as an alternative to intramuscular gold in rheumatoid arthritis.

Authors:  S R Rudge; D Perrett; M Kelly
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

Review 4.  Assessment of neutrophil function--II. Laboratory tests of neutrophil function.

Authors:  E N Wardle
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

5.  Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis.

Authors:  S W Edwards; V Hughes; J Barlow; R Bucknall
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

6.  Functions of polymorphonuclear leukocytes in early rheumatoid arthritis.

Authors:  M Leirisalo-Repo; L Paimela; S Koskimies; H Repo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

Review 7.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

8.  Proteoglycan biosynthesis by rabbit articular chondrocytes treated with D-penicillamine.

Authors:  P Legendre; M Bouakka; M Langris; J P Pujol; R Beliard; G Loyau; J Bocquet
Journal:  Agents Actions       Date:  1988-08

9.  Diclofenac inhibits monocyte superoxide production ex vivo in rheumatoid arthritis.

Authors:  A L Bell; H Adamson; F Kirk; M D McCaigue; H Rotman
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 10.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.